



Lib Oncol. 2018;46(Suppl 1):35–89
P1: NF-κB-INDUCED UPREGULATION OF miR-548as-3p INCREASES 
INVASION OF NSCLC BY TARGETING PTEN
HAKAN AKCA1,2, SAKIR AKGUN2,3, HAKAN KUCUKSAYAN2,3, OSMAN NIDAI OZES4
1 Medical Genetic Department 
(e-mails: hakca@pau.edu.tr, hakanakca@yahoo.com) 
2 ILTEM Cancer Biology Laboratory, Pamukkale University, Kinikli, Denizli, Turkey 
3 Medical Biology DepartmentSchool of Medicine 
4 Department of Medical Biology and Genetics, Akdeniz University, Antalya, Turkey
Groving number of evidences in past decade suggest that miRNAs play pivotal role in regulation of 
cell growth, and function as tumor promoter or supressor. In this line, deregulated expression of miRNAs 
have been shown to play important role in development, progression and metastasis of lung cancer. 
Although many treatment options have been developed against lung cancer in past 40 years expected 5 
year survival have not signifi cantly increased. One of the reason for this is the limitations of subclassifi ca-
tion of lung cancer at molecular level, which results in use of generalized or limited treatment options for 
lung cancer. For bett er understanding of lung cancer subtypes recent studies have focused on identifi ying 
expression profi le or transcriptional regulation of miRNAs in of lung cancers. Along this line, several dif-
ferent miRNAs have been identifi ed as biomarkers of diff erent subtypes of lung cancer. In this study, we 
wanted to determine whether TNFα-induced activation of NF-κB would induce specifi c set of miRNAs in 
non-small cell lung cancer (NSCLC) cell line H1299, and found that NF-κB signifi cantly upregulates tran-
scription of miR-548as-3p, and this targets 3’-UTR of PTEN mRNA, resulting in further activation of AKT 
pathway.The miR-548as-3p induced down regulation of PTEN accelerates invasion of this cell line.
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Wnt/β-catenin-signaling pathway is the principal force of intestinal homeostasis and morphogenesis. 
Aberrant activity of this pathway is highly implicated in cancer development, particularly in colorectal 
cancer (CRC). Although Wnt/β-catenin pathway is a well-studied pathway, the precise molecular mecha-
nisms involved in the nuclear interactions of β-catenin with DNA-binding transcription factors (other than 
TCF4) are still under debates. Human FLYWCH1 has been fi rst characterized and identifi ed in our lab as a 
novel transcription factor, which interacts with nuclear β-catenin and modulates its transcriptional activity 
(Muhammed et al., under publication). FLYWCH1 is diff erentially expressed between normal as well as 
between diff erent stages of colorectal cancers. However, we have just started exploring the biological func-
tions and mechanisms of FLYWCH1 in colon/intestinal development, homeostasis and tumor formation.
Our fi ndings suggest that FLYWCH1 protein binds to the endogenous catenin protein while nega-
tively regulates the transcription of a specifi c-subset of β-catenin/TCF target genes, regardless of Wnt 
signaling status. In this study we also propose FLYWCH1 as a new Wnt/β-catenin target gene. Our current 
study provides insights on a novel molecular mechanism mediated by FLYWCH1 and the canonical Wnt/
βcatenin pathway in CRC carcinogens. Ongoing research may ultimately off er a new potential approach(s) 
and implications for future therapeutics.
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Endoplasmic reticulum stress, a cellular condition caused by the accumulation of unfolded proteins 
inside the ER, has been recognized as a major pathological mechanism in a variety of conditions, including 
cancer, metabolic and neurodegenerative diseases. Trefoil factor family (TFFs) comprises three small pro-
teins (Tff 1, Tff 2 and Tff 3) that are present in diff erent epithelial organs, blood supply, neural tissues and 
liver. TFFs play multifunctional role in protection of mucosa through participation in apoptosis, cell migra-
tion and immune response, and their expression is deregulated in diff erent tumors. Complete diminish-
ment of liver Tff 3 expression is noticed as one of the fi rst events in early phase of diabetes development in 
multigenic mouse models of diabesity (Tally Ho mice). To elucidate the role of Tff 3 in diff erent pathologi-
cally relevant pathways we have developed new congenic mouse model Tff 3/C57Bl6/N from mixed back-
ground strain (C57Bl6/N /SV129) by using speed congenics approach. ER stress was evoked by tunicamy-
cin treatment (3ug/g of body mass) and mice were sacrifi ced 24 h later. We have monitored expression of 
diff erent oxidative and ER stress genes and relevant proinfl ammatory cytokines/chemokines. Most dra-
matic change was noticed at the level of infl ammation related genes, while markers for unfolded protein 
response and oxidative stress were not signifi cantly aff ected. ER stress induction in Tff 3 defi cient mice 
caused att enuation of gene expression for several proinfl ammatory cytokines.
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RhoD, the atypical Rho GTPase, is the less known member of the Rho protein family. RhoD limits 
endosomal movement and suppresses migration due to its interactions with actin. It has roles antagonistic 
to those of RhoA transforming protein, a known oncogen. The potential interacting partner of RhoD, kine-
sin 6 family protein KIF20B, is overexpressed in several tumor cell lines, especially bladder cancer, and 
recently has been found to be involved in the process of EMT transition. It has even been considered as a 
target of oncolytic adenovirus based therapy. Thus far, only one study has shown the infl uence of RhoD 
expression on tumor cell resistance to cisplatin, and the topic of KIF20B in tumor cell sensitivity to antitu-
mor drugs has been marginally covered in anticancer drug research. With this work we have aimed to 
elucidate the potential of both RhoD and KIF20B as possible therapeutic targets by assessing sensitivity of 
several cancer cell lines (HeLa, HeLa CK, HCT-116, CaCO-2, MDA-MB-231, MDA-MB-468 and MCF-7) to 
the widely used antitumor drugs cisplatin, paclitaxel and vincristine, after knockdown of RhoD or KIF20B.
By means of the MTT cell proliferation assay, we have found that RhoD knockdown reduces cell pro-
liferation in most of the tested cell lines, and also induces various degrees of sensitivity to cisplatin in 
tested cell lines. Out of all tested cell lines the most prominent response to KIF20B knockdown was 
observed in HeLa cells, where KIF20B knockdown induced sensitivity to cisplatin and resistance to pacli-
taxel and vincristine.
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Integrins are heterodimeric transmembrane proteins that lack enzymatic activity, instead, signalling 
is induced by binding to extracellular matrix (ECM) and forming integrin adhesion complexes, composed 
of various structural and signalling proteins, referred to as the integrin adhesome. Integrins play key roles 
in the regulation of tumor cell adhesion, survival, motility and drug sensitivity. We have previously shown 
in Cal27 tongue squamous carcinoma cells that transfection of integrin β3, giving rise to cell clone 2B1, led 
to de novo integrin αVβ3 expression and increased expression of integrin αVβ5. 2B1 cells displayed 
increased migration and invasion, and were resistant to multiple antitumor drugs as a consequence of 
integrin αvβ3-mediated loss of pSrc(Y418). The goal of this study was to analyse the adhesome composi-
tion of Cal27 and 2B1 cells by mass spectrometry (MS)–based proteomics. MS analysis identifi ed 639 pro-
teins including 19 out of the 60 consensus adhesome. Based on DAVID analysis, focal adhesion proteins 
accounted for 17% of identifi ed proteins, whereas 13.8% were ECM components. Unexpectedly, in 2B1 the 
integrin β3 subunit was not detected, whilst integrin β5 and αV subunits were only identifi ed in one out 
of fi ve sets of replicates. Interestingly, the MS analysis suggested that Cal27 and 2B1 formed focal adhe-
sions through integrin α6β4. Moreover, an integrin switching eff ect, i.e. upregulation of integrin α6β4 in 
2B1 as compared to parental Cal27 cells was observed. Additionally, in focal adhesions isolated from 2B1 
cells we found increased abundance of seven focal adhesion proteins (fi lamin A, fi lamin B, talin-1, 
α-actinin-1, Ras GTPase-activating-like protein, tensin-3, vinculin) and eight ECM proteins (trombospon-
din-1, EGF-like repeat and discoidin I-like domain-containing protein 3, laminin subunit α5, tubulin β 
chain, perlecan, transforming growth factor beta-induced protein ig-h3 and tenascin C) as compared to 
Cal27. Of particular interest was the upregulation of both integrin α6 and β4 subunits and the α6β4 ligand 
laminin 5 in the more drug resistant and motile 2B1 cells since the upregulation of these genes was already 
found to be signifi cant in the squamous cell carcinoma of the head and neck from patient samples. In con-
clusion, MS–based proteomic analysis of the integrin adhesome may be a valuable tool for identifying key 
changes in signalling pathways which can be potentially exploited for diagnostic or therapy purposes.
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Although thyroid cancer comprises only about 2% of new cancer cases, it is one of the fastest-growing 
cancer types. In fact, in Croatian population the number of newly diagnosed patients has doubled in the 
last 15 years. Thyroid cancer is more frequent in female population (about 4-fold compared to male popu-
lation) and is most usually detected at ages over 50. There is also a negative trend indicating that more 
people at the age <50 are diagnosed with thyroid cancer.
In our previous studies we observed that patients with thyroid diseases had higher baseline DNA 
damage levels, high levels of aberrantly expressed proteins (B-Raf and Ret) and altered oxidative status. 
Therefore, we performed additional analyses investigating enzymatic antioxidative defense – the activity 
of superoxide dismutase (SOD) and the levels of copper (Cu), essential trace element.
Based on 20 patients (13 female and 7 male; 7 active smokers), aged 52.3±14.4 and matched control 
group (13 female and 7 male; 7 active smokers) aged 51.1±12.7 we observed lower SOD activity in thyroid 
patients group (0.80±0.49 U/mL) compared to control group (1.24±0.43 U/mL). At the same time, plasma Cu 
concentration was higher in thyroid patients patients (1.62±0.51 μg/mL) compared to control group 
(1.27±0.50 μg/mL).
Taken together, we observed altered antioxidative defense mechanism and high Cu concentration in 
patients with thyroid diseases. Although Cu is essential for normal organism functioning, in excess it can 
have toxic potential, among other for ROS production. These results confi rmed our previous fi ndings 
where we observed more lipid peroxidation products, protein carbonyls, and altered enzymatic and non-
enzymatic antioxidative defense. The question still remains is the oxidative stress cause or consequence of 
thyroid diseases.
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Many approaches in tumour therapy are based on the oxidative stress-induced apoptosis by using 
radiotherapy or chemotherapeutics. The aim of the present study was to examine the eff ect of hydrogen 
peroxide (H2O2)-provoked oxidative stress on the expression of tumour suppressor proteins p53 and p73 
in the neuroblastoma cell line SH-SY5Y. Both proteins are involved in the initiation of apoptosis and are 
present in cells in various isoforms whose dynamic changes may contribute to apoptotic response. In a 
concentration-dependent manner H2O2 decreased cell survival, intracellular glutathione and ATP levels, 
and increased accumulation of reactive oxygen species and caspase-3/7 activity. Western blot method 
revealed an enhancement in the expression of the total p53 protein and its isoform p53α by using antibod-
ies SAPU, DO-11 and DO-12. Protein detection with KJC8 antibody that recognises all β isoforms of p53 
protein indicated reduced expression of isoforms p53β and Δ40p53β in p53-mediated cell death. H2O2 
also triggered strong induction of p73 expression, particularly the TAp73α isoform. The obtained results 
suggest that increased expressions of p53 and p73 proteins greatly contribute to reduced survival of SH-
SY5Y cells under oxidative stress conditions. Although further investigations are required to more clearly 
identify contribution of specifi c p53 and p73 isoforms to the initiation of death cascade, it seems that cer-
tain isoforms may be promising candidates as novel therapeutic targets in the anti-cancer therapy.
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3D tumor models are widely used for examination of effi  cacy and discovery of new antitumor agents. 
In this study we use HeLa (human cervical adenocarcinoma cell line) 3D spheroids as a model for exami-
nation of anticancer activity of methanol (1), ethyl-acetate (2), and hexane (3) extracts of fl owers, and also 
ethyl-acetate (4), and hexane (5) extracts of branch-body part of Turkish endemic species Hypericum per-
foratum. Spheroids were produced using a hanging drop method. Morphological features of spheroids 
were analyzed using light microscope. Cell viability of HeLa spheroids treated with extracts at concentra-
tions of 100 μg/mL and 200 μg/mL was assessed by fl uorecsent microscopy and fl ow cytometry. Changes 
in diameters of spheroids after 24h and 48h, and fl uorescence intensity after 48h of treatment were anal-
ysed by ImageJ software. The distribution of viability of cells in spheroids was calculated as a ratio of 
fl uorescence intensity of live and dead cells, respectively. After 48h of growth without treatment, the aver-
age spheroid diameters were about 450 μm. Extract 1 showed the strongest ability to reduce spheroid 
diameter to a value of 250 μm and 350 μm at applied concentrations. Extract 3 is the only one which 
increased the diameter of spferoid after 24h at lower concentration, as well as at higher concentration. That 
eff ect could be the result of breaking of the cell-cell and cell-extracellular matrix interactions in spheroids, 
what makes extract 3 the most effi  cient. After 48h the diameter was decreased. Extract 2, 4, and 5 showed 
variable eff ect to spheroid diameters. At concentration of 200 μg/mL, these extracts induced the highest 
increase of spheroid diameters, 654.7 μm, 652.4 μm and 585.8 μm, respectively. The ratio of fl uorescence 
intensity of live and dead cells in treated spheroids were much lower comparing with the control, untreated 
spheroid, 8.54. The lowest value was obtained in spheroid treated with extract 1 (200 μg/mL), and it was 
0.16. The results showed that the fl uorescence intensity of dead cells increased with increasing extracts 
concentration. Flow cytometry confi rmed cytotoxic activity of extracts. All extracts induced death in 50% 
to 80% of the cells in spheroids. Diff erent changes of diameters indicate to diff erences in mechanisms of 
activity and effi  cacy of studied extracts. The conclusion is that examined extracts have good anticancer 
activity, but need to be investigated further, especially on 3D cell culture models.
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A number of Human papillomaviruses (HPVs) were shown to be associated with various human 
cancers. Of these cervical cancer is the most important disease. Whilst the HPV E6 and E7 oncoproteins are 
responsible for cervical cancer development, it is also clear that there are diff erences of these two oncop-
roteins among the viral isolates. Good examples of this are HPV-16 E6 variants found in various geo-
graphical locations, shown to diff er in their capacities to cause cancer. Interestingly, some of these variants 
are more frequently detected in cancers than the other variants, suggesting that they exhibit very impor-
tant diff erences in their ability to induce malignancy. The aim our studies is investigate these diff erent 
cancer-causing activities which are still largely poorly understood at the molecular level.
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Majority of cancer therapeutics are designed to interact with nucleic acids and proteins. The increas-
ing knowledge of membrane lipid composition and its alterations in cancer could provide novel therapeu-
tic targets. Crown ethers represent small molecules that hold promising antitumor potential. Among other 
modes of action, crown ethers can act as ionophores, i.e. disturbing ion homeostasis and disrupting bio-
logical membranes. We showed that crown ethers inhibit P-glycoprotein and reverse multidrug resistance 
in cancer cells. Based on the previous in vitro screening, we identifi ed the proprietary diaza-crown ether 
compound as a potential antitumor drug. Inhibition of tumor growth was confi rmed on the panel of breast 
tumor cells, and in an in vivo mouse model. To unravel the mechanism of action, we choose an approach 
based on compound structure: we postulated that diaza-crown ether could: 1) potentially bind and move 
ions through the membrane and change the ion homeostasis, and 2) cause perturbations of the lipid mem-
branes throughout the cell due to its hydrophobicity. We found that compound induces K+ and Na+ fl uxes 
and modulates resting potential of cells. Physical disturbance of lipid membranes throughout the cell was 
demonstrated by increase in plasma membrane permeability and impairment of mitochondrial functions. 
The importance and/or interplay of the two mechanisms responsible for antitumor eff ects still remain to 
be elucidated.
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The interest in using 3-D in vitro models is increasing. They are designed for quick screening of for-
mulations and sensitivity with the possibility for employment in in vivo condition. Spheroid cultures pos-
sess a complex network of cell-cell contacts and advanced extra cellular matrix development, as well as 
pH, oxygen, metabolic and proliferate conditions analogous to the vascular and vascular regions of solid 
tumours. They really mimic in vivo micro tumours. The presented experiments were aimed to analyse the 
sensitivity of CaCo-2 3D stellate Spheroids for Fresh Royal Jelly (F-RY) (M) and HuIFN-αN3 for volume, 
growth, apoptosis and cytotoxicity.
The Fresh Royal Jelly (10 mg/ml) (F-RY) (M) and HuIFN-αN3 (5000 I.U. /ml) were used. The spher-
oids were fi rst treated with HuIFN-αN3 and followed with the F-RJ (M). CaCo-2 3D stellate spheroid 
volume was plott ed over a 12-day period following a 24 h incubation with HuIFN-áN3 following with RJ. 
The growth of 3D spheroid was completely impeded after incubation with 5000 I.U. /ml of HuIFN-αN3 
following with F-RJ (M) (10 mg/ml). Interestingly, following re-treatment on day 7 demonstrated greater 
inhibition of spheroid growth. The changes in the 3D stellate Spheroids volume were: from 70 μm3 to 12 
– 15 μm3 after seven days and one retreatment. The cytotoxicity level after the treatment was measured. 
The 3D stellate CaCo-2 spheroid viability declined to 20 – 25%. Additionally, the apoptosis level was deter-
mined. The increase of apoptosis of the viable 3D stellate CaCo-2 spheroid in the level of 35 – 48% was 
observed.
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Topoisomerase II-α is a molecular target of anthracyclines; several studies have suggested that topoi-
somerase II-α expression is related to response to anthracycline treatment. The objective of this study was 
to evaluate if topoisomerase II-α overexpression predicts response to anthracycline treatment in locally 
advanced breast cancer patients.
This prospective study included 50 patients with primary non metastatic locally advanced breast 
cancer according to American Joint Committ ee For Cancer Staging (T3-4; N0-3) were treated between 
January 2012 and June 2012 at Clinical Oncology Department, Tanta University Hospital.
Topoisomerase II-α, HER2, estrogen receptor (ER), progesterone receptor (PR) expression and KI-67 
were evaluated by immunohistochemistry in formalin-fi xed, paraffi  n-embedded breast tumors from 50 
patients presenting with locally advanced breast cancer.
Tumors from 50 patients, 45 (90%) showed topoisomerase II-α overexpression, patients 34 (68%) for 
ER positive, 32 (64%) for PR positive and 10 (20%) for HER2 overexpression and 16 (32%) for high KI 67. 
Signifi cant correlation was found between clinical and pathological response with topo IIA (p≤0.001), 
HER2 (p=0.005) and KI-67 (p=0.015).
1-Responders : Clinical (CR): 3 patients had co-expression of topo II and HER2, hormonal receptor 
negative and high KI-67. Clinical (PR): 43 patients majority of them had topo IIA overexpression.
2-Non responders : 4 (8%) patients all had negative (TOPOII/HER2), low KI-67and 2 had hormonal 
receptor positive and another 2 had hormonal receptor negative.
Our data support a correlation between topoisomerase II-α expression in locally advanced breast 
cancer patients and improved clinical benefi t with neoadjuvant anthracyclines based therapy.
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Imatinib mesylate (IM), a protein kinase inhibitor developed for targeted chemotherapy and sold 
under the brand name Gleevec/Glivec, is one of the most consumed anticancer drugs. Although there are 
indications that IM possesses cyto/genotoxic activities against normal non-target cells as well, there is a 
lack of information regarding the underlying mechanism involved in these actions. The aim of the present 
study was to evaluate cyto/genotoxic potential and oxidative stress responses in human peripheral blood 
lymphocytes (HPBLs) after IM treatment (0.001 – 10 μg/mL) in vitro. According to the results, cell viability 
was signifi cantly aff ected in dose- and time-dependent manner. Exposure to IM did not induce DNA 
strand breaks based on the alkaline comet assay results. On the contrary, an increase in the number of 
micronuclei originating from broken or lagging chromosomes as well as an increase of nucleoplasmic 
bridges and nuclear buds was observed suggesting that IM induces genomic instability. Nuclear buds 
represent the elimination of amplifi ed DNA, DNA repair complexes, and excess chromosomes from aneu-
ploid cells, while nucleoplasmic bridges are considered to originate from dicentric chromosomes, which 
can occur due to misrepair of DNA breaks and telomere end-fusion, and might also be observed during 
defective separation of sister chromatids at anaphase. IM also had infl uence on oxidative stress parameters 
tested. After the treatment we observed increase in the malondialdehyde concentration suggesting lipid 
peroxidation. IM reduced glutathione level indicating impairment in oxidative stress defence. Observed 
changes coincided with formation of oxidative purines detected by formamidopyrimidine-DNA glycosyl-
ase (Fpg) modifi ed comet assay suggesting IM-induced oxidative DNA lesions. The obtained results pro-
vide new evidence and clarifi cation of mechanism of action of IM-induced cyto/genotoxicity, suggesting 
that in addition to cancer cells IM can also aff ect normal non-target human cells leading to the observed 
adverse eff ects that are related to induction of oxidative stress. The concentrations that caused adverse 
eff ects in selected cells are higher than those that can be expected in the environment. However, consider-
ing that IM exerts genotoxic activity, an increased risk for human health at chronic exposure to low con-
centrations cannot be completely excluded.
Supported by EU FP7 “CytoThreat” and the Foundation of the Croatian Academy for Sciences and 
Arts
Lib Oncol. 2018;46(Suppl 1):35–89
50
P14: IN VITRO EVALUATION OF ANTI-MIGRATION 
AND ANTI-ANGIOGENIC EFFECT OF FUCUS VIRSOIDES SEAWEED 
AND INFLUENCE OF SEASONAL VARIATIONS
NAĐA GROZDANIĆ1, VESNA MAĆIĆ2, GORDANA ZDUNIĆ3, KATARINA ŠAVIKIN3, 
IVANA MATIĆ1, ZORAN KLJAJIĆ2, TATJANA P. STANOJKOVIĆ1
1 Institute for Oncology and Radiology of Serbia, Belgrade, Serbia 
(e-mail: nadjagrozdanic@gmail.com) 
2 Institute of Marine Biology, Kotor, Montenegro 
3 Institute for Medical Plant Research “dr. Josif Pančić”, Belgrade, Serbia
Seaweed species from Fucus genus are well known for their anticancer properties and they may pos-
sess nutritional value and several health benefi cial properties. Literature data about biological activity of 
endemic species Fucus virsoides are in scarce. The aim of this study was to examine anti-migration and 
anti-angiogenic activities of extract and fractions of F. virsoides and infl uence of seasonal variations. Mate-
rial and Methods: F. virsoides was collected from Adriatic Sea Boka Kotorska bay in October and July. 
Dichloromethane-methanol extract, petrol-ether, ethyl-acetate and butanol fractions were made. They 
were tested for their anti-migration and anti-angiogenic properties (subtoxic IC20 concentrations) against 
human endothelium-derived permanent EA.hy926 cell line using scratch assay and tube formation assay. 
Results: We observed signifi cant diff erence between activities of two F. virsoides samples taken in diff er-
ent season. The best anti-migration eff ect showed autumn picked sample and its ethyl-acetate fraction 
with scratch gap reduction of 9.80±0.49% after 24 hours and 23.61±2.39% after 48 hours exposure, followed 
by petrol-ether (15.17±2.16%, 26.62±1.84%) dichloromethane-methanol extract (19.55±3.93%, 40.28±6.16%), 
while butanol fraction had poorest eff ect (45.65±8.89%, 72.66±13.28%). Summer sample showed less poten-
tial for migration inhibition; gap reduction in cell samples treated with dichloromethane-methanol extract 
was 38.68±2.55% after 24 hours and 54.37±2.31% after 48 hours, followed by samples treated with petrol-
ether fraction (41.36±9.56%, 45.60±6.34%), ethyl-acetate (49.84±8.78%, 87.65±1.37%) and butanol fraction 
(85.37±7.65%, 99.98±0.02%). Angiogenic assessment demonstrated that ethyl-acetate fraction of both sam-
ples exerted signifi cant anti-angiogenic eff ect and prevented any tube formation or cell connections, fol-
lowed by autumn samples of whole extract and petrol-ether fraction where we sporadically found litt le 
cell to cell interaction. All other samples and control EA.hy 926 cells showed polygonal structures, com-
plex meshes and large vessel structures. Conclusion: Our research showed that there was signifi cant sea-
sonal variation in anti-migration and anti-angiogenic activity of extracts and that some fractions compared 
to the whole extract exerted bett er activity. Further analysis of Fucus virsoides extract and fractions is 
needed to determine the most powerful component that can stop migration and angiogenesis.
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In metastatic melanoma tumor suppressor protein p53 is not functional, although it is rarely mutated 
(less than 10%). Despite the low rate of mutations, p53 fails to function as tumor suppressor and tumor 
cells continue to proliferate and spread. Therefore, the question arises what in the metastatic melanoma 
prevents the wild type p53 protein to function. Since p53 interactions play a signifi cant role in tumorigen-
esis, we have investigated whether the p53 protein function can be altered by interactions with p53 low 
molecular weight isoforms, p73 isoforms, and NME and GLI families of proteins. Therefore, we studied 
the protein expression profi le of p53 and its potential interaction partners (p73/NME/GLI) in metastatic 
melanoma and in adjacent healthy skin tissue. In the study on 38 patients with metastatic melanoma, the 
expression of p53, p73, NME and GLI protein families was determined by western blot analysis. Protein 
expression analysis showed elevated expression of Δ133p53α, Δ160p53α, ΔNp73α, NME1, NME2, 
GLI1_160 kDa, GLI1_130 kDa and GLI2_133 kDa in tumor samples compared with healthy tissue samples. 
Strong correlations were detected only between TAp73β and p53α, and GLI3R and p53α. The remaining 
correlations were mostly moderate (p53α with Δ160p53α, TAp73α, ΔNp73α, GLI1_118 and GLI1_160). 
Interestingly, Δ133p53β was negatively correlated with p53α. We have shown that p53 forms complexes 
with p53 and p73 isoforms hence inhibiting its transcriptional and apoptotic activity. Although NME and 
GLI did not form complexes with p53, they were able to modify its activity. Defi ning the interactions 
between protein p53 and other proteins could contribute to bett er understanding of the molecular basis of 
melanoma and fi nally lead to the development of new approaches in melanoma treatment.
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Proper immune response is an important defense mechanism, which deters cancer development and 
progression. However, chronic infl ammation can facilitate tumorigenesis. The role of infl ammation in 
urinary bladder cancer (BC) pathogenesis is poorly understood. It is well documented that one of the main 
molecular links between infl ammation and cancer are interleukin-6 (IL6) and its downstream transcription 
factor – Stat3. Here, by using N-butyl-N-(4-hydroxybutyl)-nitrosamine (BBN)-induced bladder cancer 
mouse model, we tested the role of IL6 and Stat3 in bladder cancer development and progression. In our 
experiments we used genetic IL6 defi cient mice (IL6 KO) model and mice with urothelial specifi c condi-
tional deletion of Stat3 as well as chemical inhibitor of Stat3. We employed histopathological, immunohis-
tochemical approaches and gene expression profi ling to demonstrate an essential role of IL6 and Stat3 in 
BC development. Results show that inhibition of Stat3 activation slows down progression and invasive-
ness of bladder cancer in BBN-induced mouse model. Interestingly, Stat3 activation in BC occurred largely 
independently of IL6 signaling, as IL6 defi cient mice still developed BC tumors with marked Stat3 activa-
tion. Taken together, our study demonstrates an important role of Stat3 signaling in bladder cancer and 
creates a rationale to test therapeutic potential of Stat3 inhibitors in patients with bladder cancer.
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Gemcitabine (GEM) is a chemotherapeutic drug and the standard treatment option for pancreatic 
cancer patients. Although some patients respond well in the treatment fi rstly, development of resistance is 
commonly observed in clinic. To dissect the mechanism underlying GEM resistance, we screened for the 
epigenetic modifying enzymes that are increased in GEM-resistant pancreatic cancer cells and identifi ed 
21 upregulated enzymes in resistant cells. We fi rst addressed the functional role of protein arginine meth-
yltransferase 3 (PRMT3) in chemoresistance. We found the upregulation of PRMT3 in GEM-resistant pan-
creatic cancer cells. By using proteomics approach, we identifi ed a number of PRMT3-interacting proteins. 
One candidate gene possibly involves in the chemoresistance is the transporter ATP binding cassett e sub-
family G member 2 (ABCG2). In this study, we will introduce how PRMT3 modulates the expression of 
ABCG2 via a novel post-transcriptional mechanism. Our results suggest that PRMT3 could be a potential 
target to overcome GEM resistance.
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Pancreatic adenocarcinoma (PDAC) is the fourth leading cause of cancer-related death in the U.S. and 
in Taiwan. Due to its low 5-year survival rate as 5%, identifi cation of novel mechanisms and therapeutics 
for PDAC is needed. One of the characteristics of PDAC is perineural invasion (PNI), in which neuron 
serves as a source of protumorigenic factors and a route for cancer metastasis. To investigate the impact of 
neurogenesis on PDAC formation and prognosis as well as its counteracting therapeutics, we analyzed the 
prognosis prediction power of neural factors in silico and found neurotensin (NTS) and its receptor 1 
(NTSR1) predicted poor PDAC overall survival. In vitro we found NTS as synthetic peptide or from con-
ditioned medium of either pancreatic neuroendocrine tumor (PNET) or diff erentiated neuron increased 
slightly the proliferation and anchorage-dependent growth of human and mouse PDAC cell lines, while 
increased mainly the migration and invasion of above cell lines. Besides, knockdown of NTSR1 in human 
and mouse PDAC decreased their response to neurotensin during migration and invasion, and knock-
down of NTS in diff erentiated neuron decreased its induction of PDAC migration and invasion. Moreover, 
in silico analysis revealed that PI3K inhibitor targeted NTS- and NTSR1-high PDAC in human patients, 
and in vitro result validated the suppression by PI3K inhibitor wortmannin and/or GDC-0941 on NTS-
induced migration and invasion in human and mouse PDAC. In mouse tissue we found spontaneous 
pancreatic cancer mouse models LSL-KrasG12D/+; p53Loxp/+;Pdx-1-Cre (KPC) and the one with addi-
tional APC mutation (KPA) displayed increased NTS and NTSR1 expression compared to that of wildtype 
C57BL/6, and NTS colocalized with neuron marker glial fi brillary acidic protein (GFAP). To sum up, pres-
ent study identifi ed in silico neural factor NTS and its receptor 1 predicted poor PDAC survival and vali-
dated in vitro and in mouse tissue the contribution of NTS-NTSR1-PI3K axis to PDAC formation and 
neurogenesis.
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Medicinal mushrooms are for millennia widely appreciated as natural sources of bioactive substances 
and are recognized as signifi cant immunomodulatory and antitumor agents. In the last 50 years there has 
been an increased interest in the use of fungi in the (traditional) medicine as well as in determining their 
therapeutic and medicinal properties, resulting in exponential growth of the number of scientifi c research 
papers on their impact on animal and human organism. This paper describes the eff ects of two commercial 
preparations from medicinal mushrooms, tableted preparation AGARIKON.1® and liquid preparation 
AGARIKON PLUS® (manufacturer: Dr Myko San – Health from Mushrooms). These extract preparations 
from various mushroom species with proven antitumor eff ects were compared in various combinations, 
with or without 5-fl uorouracil (5-FU), which is a common antimetabolite class drug used in treating colon 
cancer. An important hypothesis throughout is that the blend of diff erent medicinal mushroom substances 
of the same class of compounds achieved synergistic eff ects, and consequently signifi cantly stronger cyto-
toxic and other eff ects. The preparations AGARIKON.1® and AGARIKON PLUS® diff er signifi cantly in 
their polysaccharide to polyphenol contents ratio which diff erentiates their immunological and antimeta-
static eff ects. We have simulated an advanced disease model by starting with the therapy late in the course 
of the disease. Two models of experimental design in studying survival were used: curative and preventa-
tive. Besides observed eff ects on survival, we also recorded the eff ects of mushroom preparations with or 
without cytostatic drug on angiogenesis and tumor invasiveness by measuring MMP-2, MMP-9 and VEGF 
levels, as well as immunological parameters such as macrophage polarization by measuring NO, arginase 
levels, as well as by using Th1/Th2/Th17 cytokine panels. Additionally, we have observed direct cytotoxic 
eff ects of mushroom preparations on human colorectal cell lines using MTT assay and proved their apop-
tosis inducing properties by fl ow cytometry. The results show signifi cant benefi cial eff ects on various 
parameters related to tumor suppression and show that medicinal mushrooms preparations alone and in 
combination with standard therapies have a major role in this in vivo model of colorectal cancer, which 
should be further explored in the clinic.
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Coumarins constitute a large family of oxygenated heterocyclic secondary metabolites widely dis-
tributed in plants. Natural and synthetic coumarins have att racted interest of scientist because of their 
broad spectrum of pharmacological activities among which are acting as an antioxidants and antitumor 
agents. Novel of coumarin-1, 2, 3-triazole hybrids were designed to evaluate their antiproliferative eff ect 
against carcinoma cells (HeLa, CaCo-2, SW620 and HT29), leukemia cells (K562 and CCRF-CEM), lym-
phoma cells (Raji and HuT-78), and MDCK as a normal cell line. Antiproliferative eff ect on coumarins 
hybrids was estimated after 72h by MTT test. Membrane integrity, as an indicator of cytotoxicity of selected 
hybrids was determined after 3, 6, 12 and 24 h by LDH release assay. The antioxidant capacity of new 
coumarine hybrids was determined by DPPH scavenging during 1h. Flow cytometry was used to deter-
mine cell cycle, as well as detection of ROS and apoptosis in K562 cells. Among tested coumarin hybrids, 
6,7 – dihydroxycoumarins showed the highest antioxidative activity with meaningful cell growth inhibi-
tion of tumor cells. Disrupted cell membrane integrity is apparent after 3h of incubation with >25% of LDH 
released. Tested hybrids caused accumulation of cells mostly in G1 and G2/M phases in cell cycle. One of 
tested dihydroxycoumarin showed reduction of ROS accumulation in K562 cells. Induction of apoptosis 
in K562 cells was not detected. Obtained results suggest that further biological evaluation of new synthe-
sized coumarines hybrids is required.
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Class I phosphoinositide 3-kinase (PI3K) signaling is a major pathway in human cancer development 
and progression. Amongst the four PI3K isoforms, PI3Kα and PI3Kβ are ubiquitously expressed while 
PI3Kγ and PI3Kδ are mainly found in leukocytes. Until now, PI3K targeting in solid tumors has focused 
on inhibiting PI3Kα- and PI3Kβ-mediated cancer-cell-intrinsic PI3K activity. The role of PI3Kδ in solid 
tumors is unknown. Here, we evaluated the eff ects of PI3Kδ using established hepatocellular carcinoma 
(HCC) cells, malignant hepatocytes derived from patients with advanced HCC, murine models, and HCC 
tissues using RNA-sequencing, quantitative PCR, immunoblott ing, immunofl uorescence, microarray, LC/
MS-MS, and kinase assay. We established a chemical carcinogenesis model of liver malignancy, which 
refl ects the malignant phenotype and the in vivo environment of advanced HCC. In this in vivo advanced 
HCC-mimic system using HCC-cells treated with H2O2, we showed that H2O2 selectively increases PI3Kδ 
activity while decreasing that of other class I PI3Ks. Blocking PI3Kδ activity with a PI3Kδ inhibitor or 
siRNA-mediated PI3Kδ gene silencing inhibited HCC-cell proliferation and dampened key features of 
malignant HCC, including the upregulation of telomerase reverse transcriptase (TERT). Mechanistically, 
H2O2 induced oxidative modifi cation of the serpin peptidase inhibitor, SERPINA3, blocking its ubiquitin-
dependent degradation and enhancing its activity as a transcriptional activator of PI3Kδ and TERT. High 
PI3Kδ levels in HCC were found to correlate with poor survival rates, with human advanced HCC show-
ing positive correlations between the protein levels of oxidized-SERPINA3, PI3Kδ, and TERT. Thus, PI3Kδ 
plays signifi cant roles in malignant liver tumors.
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Cancer cells that undergo an epithelial to mesenchymal transition (EMT) become invasive and drug-
resistant. Also, such cells form primary and metastatic tumors, making them functionally indistinguish-
able from cancer stem cells (CSC). EMT can be induced experimentally by overexpression of transcription 
factors, such as Snail or Twist. Thus, a breast EMT/CSC model was established by Twist overexpression in 
immortalized human mammary epithelial cells (HMLE). Using this model, salinomycin was identifi ed to 
be selectively toxic towards CSCs. Salinomycin is a K+/H+ exchanger that can aff ect cation transport across 
diff erent cell membranes. However, the exact mechanism of the observed selectivity remains largely 
unknown.
We have shown that salinomycin aff ects postranslational modifi cations of membrane proteins in the 
aforementioned cell model: HMLE-Twist (EMT) and HMLE-pBp (control) cell lines. We demonstrate that 
salinomycin induces ER and Golgi apparatus stress leading to disturbances in secretory pathway which 
may represent a key vulnerability of EMT cells. Besides, modifi cations of N-glycans in the Golgi apparatus 
are pH dependent and a disruption of pH homeostasis in Golgi is visible in change of N-glycan structures. 
Therefore, we also investigated the eff ect of salinomycin on N-glyco profi le of the CSC model. We corre-
lated its eff ect with monensin, another ionophore, which is a well described inhibitor of Golgi function. 
The results show that the N-glycome profi le of secreted proteins changed on both cell lines after the treat-
ment with salinomycin. The most evident diff erence in profi les after treatment, is the loss of highly 
branched complex glycan structures and the relative increase of simpler glycans. Importantly, the eff ect of 
salinomycin is similar to monensin and is more prominent on HMLE-Twist than on HMLE-pBp cell line.
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Testicular Germ Cell Tumours (TGCT) are the most frequent malignancies in young male population 
and believed to be initiated by epimutations, i.e. aberrant epigenetics. Teratocarcinoma is a mixed TGCT 
merging teratoma and embryonal carcinoma in a single neoplastic entity. Teratoma is the most diff erenti-
ated TGCT type encompassing all three germ layer derived tissues. EC cells constitute a pluripotent “core” 
of teratocarcinomas, are highly similar to embryonic stem cells and express same pluripotent markers: 
OCT4, SOX2 and NANOG. EC cells may diff erentiate into teratoma tissue or retain their pluripotency. The 
well-known and established experimental mouse model of teratocarcinoma, at Biology Department of 
Zagreb’s School of Medicine, has been defi ned based on a histological/histochemical basis and its molecu-
lar signature has not yet been comprehensively studied. The aim of this study was to compare the rate of 
apoptotic and proliferative activity in the experimental mouse model to human teratocarcinomas.
Formalin-fi xed paraffi  n-embedded tissue from 10 human testicular teratocarcinoma and 10 animal 
model tumors was used for immunohistochemical detection of Caspase-3 and PCNA expression. Slides 
were analysed semi-quantitatively, at the area of strongest reaction (“hot-spot”), by pathologist, graded 
from 0-3, depending on the percentage of reactive cells. Data was analysed in GraphPad Prism using 
Mann-Whitney test.
Results have shown diff erence in rate of apoptosis between human and experimental mouse terato-
carcinomas, with mouse showing higher rate (>25% of positive cells) in 64% of tumors compared to 30% 
of human with highest reaction. PCNA quantifi cation has shown comparable levels of PCNA expression 
in EC regions of experimental mouse model and human teratocarcinomas, while in the teratoma regions 
mouse model has a higher proliferative activity defi ned with PCNA staining.
Some of diff erences could be att ributed to the fact that this study was a pilot with a relatively small 
sample pool, intragroup diff erence in biological development and “age” between human teratocarcino-
mas as well as intergroup diff erence in biological development between human and mouse model terato-
carcinomas. Further analysis of expression between comparable regions should be done to account for 
these diff erences.
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FAS/CD95 is a member of the death receptor superfamily that can induce apoptosis when binds to its 
cognate ligand FASL/CD95L and it acts as the key component of the extrinsic death pathway. PUMA is a 
pro-apoptotic protein that involved in p53-dependent and independent apoptosis. This study reports on a 
relevant function of PUMA after an extrinsic FAS-apoptosis induction in liver cancer (hepatocellular car-
cinoma; HCC) cells. For the in vivo study, the mRNA analysis of FAS, FASL, and PUMA were collected 
from 111 patients undergoing liver resection without any prior treatments (39 HCC, 30 peri-HCC, 31 dis-
tal/cirrhosis); liver donors were used as control (11 normal). For the in vitro study, human immortalized 
hepatocyte cell line IHH and HCC cell line HepG2 were used. Apoptosis-induction was performed by 
using anti-FAS (DX2) at concentrations of 250 ng/ml and 500 ng/ml for 24 hours. Flow cytometry was per-
formed for FAS/FASL positivity and Annexin-V- PI apoptosis test, quantitative real-time PCR for mRNA 
expressions, and growth curve test for cells viability. The expressions of FAS and FASL mRNA were sig-
nifi cantly increased in HCC as compared to normal tissues (p<0.05). PUMA mRNA was positive in 13/32 
(41%) HCC tissue samples, 19/27 (70%) in peri-HCC and 24/31 (77%) cirrhosis tissues samples. For in vitro 
study, anti-FAS treatment did not aff ect cells viability up to 13 days. After 24 hours treatment, PUMA 
mRNA was up regulated only in IHH where the transcription factors p53 and c-Myc were up-regulated, 
while NF-κβ was unchanged. In contrast, all these three factors were slightly down-regulated in HepG2 
while TNF-α was signifi cantly up-regulated. In both models, the importance of PUMA and FAS/FASL in 
HCC pathologies was demonstrated. Acute treatment by anti-FAS dysregulated transcription factors p53, 
c-Myc and NF-κβ suggesting their correlation with the PUMA. The diff erential patt ern of expression 
between hepatocyte and HCC cell lines suggests a less-eff ective FAS-induction apoptosis in HCC.
This study was funded by the Indonesia Endowment Fund for Education (LPDP) and by an internal 
grant of the Italian Liver Foundation.
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Six extracts were prepared from Hypericum perforatum, an endemic plant species which grows in 
Turkey: methanol (1), ethyl-acetate (2), and hexane (3) extracts of branch-body part, as well as methanol 
(4), ethyl-acetate (5), and hexane (6) extracts of fl owers. The aim of this research was to evaluate the anti-
cancer properties of these extracts. The cytotoxic activity of the extracts was examined against three human 
cancer cell lines: cervical adenocarcinoma HeLa, chronic myelogenous leukemia K562, and lung carci-
noma A549, as well as against normal human lung fi broblasts MRC-5. Changes in the cell cycle of treated 
HeLa cells were analyzed by fl ow cytometry. Measurement of mRNA expression levels in HeLa cells was 
done by quantitative real time PCR. Five examined extracts (2-6) showed selective concentration-depen-
dent cytotoxic eff ects on HeLa, K562 and A549 cancer cells. Extract 1 exhibited weak cytotoxicity. Among 
tested cancer cell lines, HeLa cells were the most sensitive to the cytotoxic activities of the extracts 6, 5 and 
3 with IC50 values of 6.76, 8.37, and 10.91 μg/mL respectively. In addition, the extracts 4 and 2 exerted 
pronounced cytotoxicity against HeLa cells with IC50 values of 23.74 and 34.67 μg/mL. The mechanisms 
of the anticancer eff ects of the extracts 2-6 in HeLa cells were further examined. The investigated extracts 
applied at 2IC50 concentrations for 24 h caused increase in the percentage of HeLa cells within subG1 cell 
cycle phase when compared with untreated, control cell samples. These extracts demonstrated the ability 
to trigger apoptosis in HeLa cells through activation of caspase-3, the main eff ector caspase. To explore the 
possible antimetastatic and anti-angiogenic properties of Hypericum perforatum extracts, their eff ects on 
gene expression levels of matrix-metalloproteinase-2 (MMP2), matrix-metalloproteinase-9 (MMP9),matrix-
metalloproteinase inhibitor 3 (TIMP3), and vascular endothelial growth factor A (VEGFA) in HeLa cells 
were determined. All tested extracts remarkably decreased the expression levels of each of the four exam-
ined genes in HeLa cells after 24 h incubation. In conclusion, results of our research may suggest the 
 promising anticancer potential of extracts obtained from Hypericum perforatum, plant species endemic to 
Turkey.
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Macropinocytosis is a highly conserved large-scale endocytic process utilized by eukaryotic cells to 
internalize extracellular fl uid. It is an actin cytoskeleton-driven process, regulated by Ras proteins. On 
early endosomes, Ras signaling needs to be precisely regulated and key factors responsible for the termi-
nation of Ras signaling in timely manner are GTPase activating proteins (GAPs), which inactivate Ras by 
promoting the hydrolysis of the GTP bound to active Ras into GDP. In our work, we characterized Dictyo-
stelium discoideum RasGAP protein involved in macropinocytosis regulation, an IQGAP-related protein 
IqgC, which we showed to be a genuine RasGAP. Using mass spectrometry, yeast two-hybrid and bimo-
lecular fl uorescence complementation assays, we showed that IqgC directly binds active RasG, one of the 
main positive regulators of macropinocytosis in Dictyostelium. RasGAP activity of IqgC towards RasG 
and human H-Ras was demonstrated using luminescence based GAP assay. Confocal microscopy con-
fi rmed that IqgC colocalizes with RasG and its localization is almost exclusively confi ned to macropino-
somes. Phenotypic assays showed that IqgC negatively regulates macropinocytosis and restrains the size 
of macropinosomes. The iqgC- cells have a mild cytokinesis defect but no growth defects when grown in 
shaken suspension. Taken together, our results show that IqgC is a RasGAP that negatively regulates RasG 
signaling in Dictyostelium discoideum specifi cally during macropinocytosis. In higher eukaryotes, owing 
to the development of multicellularity, macropinocytosis is no longer used for acquiring nutrients. Instead, 
it is used for a range of other physiological processes; for example, dendritic cells use constitutive mac-
ropinocytosis to internalize soluble antigens. However, in recent years it has become apparent that in Ras-
driven tumors cancer cells upregulate the macropinocytic pathway and utilize it in a similar way to amoe-
bae, as a means of nutrient uptake. More precisely, it has been shown that they use it to internalize ATP 
and serum albumin as a source of glutamine to sustain cell proliferation, which indicates possible alterna-
tive strategies for approaching anti-cancer therapies and emphasizes the need to understand the process 
of macropinocytosis in depth.
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Multidrug resistance (MDR) is a known characteristic of many cancers and is a major cause of failure 
of chemotherapy treatments. Various cellular pathways are responsible for this phenomenon, including 
overexpression of ATP binding cassett e (ABC) transporters called ABCB1 (MDR1/P-glycoprotein) and 
ABCG2 (BCRP) by cancer cells, which makes this group of proteins a valuable target for cancer therapy by 
reversal of MDR. Salinomycin, naturally occurring potassium (K+) ionophore, was shown to inhibit P-gp 
transporter and to reverse MDR eff ectively. Salinomycin is a K+/H+ exchanger that can aff ect cation trans-
port across diff erent cellular membranes and thus impact on membranes’ bioenergetic performance, 
including mitochondrial membrane polarization and function.
Based on the above-mentioned studies and anticancer activity of crown-ethers that act as K+ 
 ionophores (previously published by our group), we showed that these compounds exhibit inhibitory 
eff ect towards ABC transporters, disrupt the potassium transport and modulate mitochondrial membrane 
transport.
In this study, we showed the eff ect of adamantane-substituted monoaza- and diaza-18-crown-6 ether 
compounds on MDR reversal and their eff ect on mitochondrial membrane function, depending on their 
lipophilicity as well as on the chemical structure of the linker to adamantane moiety. Compounds that 
showed as the most potent P-gp and ABCG2 inhibitors were able to sensitize cancer cells to conventional 
chemotherapeutics paclitaxel and mitoxantrone, the substrates of P-gp and ABCG2 transporters, respec-
tively. These data are promising and demonstrate a potential use of crown ethers in cancer therapy, by 
their ability to reverse MDR.
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Ovarian cancer is the eighth most common tumor type in women worldwide, and the most lethal 
female gynecological malignancy with almost no diff erence in mortality between developed and develop-
ing countries. Because it remains asymptomatic for long time it usually gets diagnosed in late stages when 
treatment options are limited and overall survival remains poor.
Hedgehog-GLI (HH-GLI) signaling pathway is one of the major developmental pathways and is 
responsible for the formation of various tissues and organs, including ovaries. In the adult organism it is 
involved in the stem cell maintenance, tissue homeostasis and in the immune response.
Survivin is an inhibitor of apoptosis protein (IAP) that plays a role in multiple processes, including 
proliferation and cell survival. It is widely expressed during development, but rarely expressed in adult 
tissues. Survivin expression in tumors has been associated with aggressive behavior, resistance to radia-
tion and chemotherapy and poor survival. Survivin has at least 5 diff erent splice variants (wild type, 2α, 
2B, 3B and deltaEx3). The expression levels of various survivin isoforms have been associated with clinic-
pathologic characteristics in some cancers. Survivin has been recently shown to be a direct target of HH/
GLI signaling pathway and has several binding sites for GLI transcription factors in its promoter region.
The aim of this study was to investigate the expression of survivin isoforms in SKOV-3 ovarian carci-
noma cell line with GLI1-3 knock-outs (KO) treated with GANT-61 pathway inhibitor.
GLI1 and GLI2 KO lines show downregulation of survivin isoforms, while GLI3 KO has no eff ect on 
expression of survivin isoforms. GLI1 KO regulates expression of all fi ve analyzed isoforms, while GLI2 
aff ects only 3B and deltaEx3 isoforms. Combined treatment of KO cell lines with GANT-61 shows addi-
tional inhibitory eff ect of GANT-61 on wild type, 2α and 2B isoforms, suggesting that these isoforms are 
regulated by both GLI1 and GLI2. On the other hand, 3B and deltaEx3 isoforms are not additionally down-
regulated by GANT-61 treatment, suggesting a diff erent regulatory mechanism for these two isoforms.
65
Lib Oncol. 2018;46(Suppl 1):35–89
P29: DEVELOPMENT OF RESISTANCE TO ANTITELOMERASE THERAPY 
IN BREAST CANCER CELLS SUBMITTED TO LONG-TERM EXPOSITION 
TO MST-312
DIEGO MADUREIRA DE OLIVEIRA1, KAROLLYNE DA SILVA MORAIS1, 
ANA FLÁVIA REIS GUIMARÃES1, GISELLE PINTO DE FARIA LOPES2
1 Multidisciplinary Laboratory of Human Health, University of Brasilia, Federal District, Brazil 
(e-mail: dmadureira@unb.br) 
2 National Cancer Institute of Brazil, Rio de Janeiro, Brazil
Telomerase is an enzyme responsible for telomere maintenance in almost all human cancer cells 
(80-90%) but generally not expressed in somatic ones. Therefore, antitelomerase therapy is a potential 
revolutionary therapeutic strategy, and antitumor activity of telomerase inhibitors has been extensively 
studied recently. However, the eff ects expected from treatment with telomerase inhibitors, such as break-
age-fusion-bridge cycle or cell senescence, will appear only after many cell divisions. In this work, the 
consequences of long-term exposure of human breast cancer cells to telomerase inhibitor MST-312 were 
investigated. This compound presented cytotoxic action and promoted telomere erosion, senescence and 
chromosome aberrations, but in a small proportion. As main eff ect, the chronic exposition caused cell 
adaptation by diff erent mechanisms and development of resistance to antitelomerase action of MST-312. 
In MDA-MB-231 cells, selection of clones with very long telomeres was responsible for the new pheno-
type. In the other hand, MCF7 cells overexpressed telomerase in response to the inhibitor. Classical multi-
drug resistance mechanisms (MDR) and alternative lengthening of telomeres (ALT) had no relevant role 
in the development of resistance. Both of these mechanisms are potential causes of therapeutic failure, and 
have to be evaluated when considering antitelomerase therapy for breast cancer.
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Notch signaling is one of the most important developmental pathways present in all organisms. 
Canonical branch of the signaling cascade aff ects target genes and regulates cell metabolism through reg-
ulation of expression. Non-canonical branch represents a complicated network of signaling crosstalk. The 
basis for non-canonical signaling is direct interaction with eff ectors from diff erent signaling cascades, 
including but not limited to Akt, Hif, NFκB, mTOR and p53. This branch is still relatively undiscovered in 
spite of great impact it can have on cellular development. One of the possibilities of interaction is between 
p53 and MAML.
The region of MAML responsible for interaction with p53 is located on the N-terminal portion of 
MAML, in the section that was identifi ed as dnMAML due to its ability to inhibit canonical Notch. To test 
the hypothesis of dnMAMl aff ecting p53 availability in the cell dnMAML was incorporated into a carrier 
molecule to enable cellular delivery and tested on three breast cancer cells lines (MCF7, MDA-MB 231 and 
MDA-MB 468). The cells were chosen due to their diff erence in p53 status. Cells were treated with dnMAML 
and empty carrier to determine if there is a change in p53 quantity after treatment with dnMAML. p53 was 
identifi ed using Western blot and its quantity in diff erent samples determined by total protein evaluation. 
The treated samples showed decreased levels of p53 when dnMAMl was present compared to both 
untreated controls and samples treated with only the carrier protein.
The interaction was then modeled in silico using structure information from the PDB database. The 
models were rendered using AutoDock software to fi nd the best binding solution for the two molecules. 
The model can be used to further determine changes in binding profi les when diff erent p53 mutations are 
taken into account.
The presented results need to be further confi rmed using direct interaction methods like mammalian 
two hybrid method, but show that there is still a great deal to be discovered about crosstalk between sig-
naling cascades and even more about the role Notch pathway had in development and regulation of cel-
lular fates in cancer.
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Ovarian cancer is the leading cause of death from gynecological malignancies in the Western world. 
Its high death rate is a result of the fact that >60% patients are diagnosed in advanced stage of the disease. 
Hedgehog-GLI (HH-GLI) signaling pathway is involved in embryonal ovarian development, but its atyp-
ical activation can lead to diff erent types of ovarian tumors. Our previous studies showed aberrant HH-
GLI activity in some ovarian tumor types and hypermethylation in the promoter of tumor suppressor gene 
PTCH1 (Ozretić et al. Int J Oncol. 2017; Musani et al. Gene. 2013; Sabol et al. Int J Oncol. 2012; Maurac et 
al. Int J Gynecol Pathol. 2012; Cretnik et al. Int J Mol Med. 2007). We hypothesize that changes in the 
expression of miRNA molecules related to the HH-GLI signaling pathway genes contribute to the devel-
opment of high-grade serous ovarian cancer (HGSOC), the most malignant type and most diffi  cult to 
detect at an earlier stage.
We conducted miRNA and gene expression profi ling of 16 HGSOC and 8 healthy Fallopian tube fresh 
frozen tissue samples as a control (Reade et al. J Obstet Gynaecol Can. 2014) with Agilent SurePrint G3 
Human miRNA 8x60K Microarray Kit and Agilent SurePrint G3 Human Gene Expression v3 8x60K Micro-
array Kit, respectively. Microarray data was analyzed using R/Bioconductor packages AgiMicroRna and 
limma. Online tools DianaMicroT, miRDB, RNA22-HSA and TargetScan were used to predict target genes 
of discovered diff erentially expressed miRNAs. Expression of selected miRNAs and genes was verifi ed 
using TaqMan and SYBR Green qPCR, respectively, on an extended set of 10 Fallopian tube and 47 HGSOC 
samples.
Data fi ltration gave a list of 55 miRNAs diff erentially expressed in HGSOC: 32 up- and 23 down-
regulated. In addition, 1,090 genes were signifi cantly over- and 1,692 were under-expressed in HGSOC. By 
comparing a list of predicted miRNA target genes and diff erentially expressed HH-GLI pathway genes we 
revealed a couple of combinations of miRNAs and their target genes: GRK3 / hsa-miR-513a-5p; BCL2 / 
hsa-miR-96-5p and hsa-miR-21-5p; IHH / hsa-miR-103a-3p, hsa-miR-107 and hsa-miR-16-5p; and GLI3 / 
hsa-miR-200b-3p. Co-expression of all those target genes / miRNAs has been confi rmed in an extended set 
of samples. Additional in vitro verifi cation will be continued with in vivo approach.
Our results highlighted several candidate miRNAs potentially targeting HH-GLI pathway genes. 
When additionally verifi ed, they could be used as potential diagnostic and prognostic markers or even 
therapeutic targets for HGSOC.
This study was funded by the Terry Fox Foundation, City of Zagreb and Croatian Science Foundation 
(IP-2016-06-1268).
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Macroautophagy (autophagy) is an evolutionarily conserved recycling and stress response mecha-
nism. Active at basal levels in eukaryotes, autophagy is upregulated under stress providing cells with 
building blocks such as amino acids. A lysosome-integrated sensor system composed of RRAG GTPases 
and MTOR complex 1 (MTORC1) regulates lysosome biogenesis and autophagy in response to amino acid 
availability. Stress-mediated inhibition of MTORC1 results in the dephosphorylation and nuclear translo-
cation of the TFE/MITF family of transcriptional factors, and triggers an autophagy- and lysosomal-related 
gene transcription program. The role of family members TFEB and TFE3 have been studied in detail, but 
the importance of MITF proteins in autophagy regulation is not clear so far. Here we introduce for the fi rst 
time a specifi c role for MITF in autophagy control that involves upregulation of MIR211. We show that, 
under stress conditions including starvation and MTOR inhibition, a MITF-MIR211 axis constitutes a 
novel feed-forward loop that controls autophagic activity in cells. Direct targeting of the MTORC2 compo-
nent RICTOR by MIR211 led to the inhibition of the MTORC1 pathway, further stimulating MITF translo-
cation to the nucleus and completing an autophagy amplifi cation loop. In line with a ubiquitous function, 
MITF and MIR211 were co-expressed in all tested cell lines and human tissues, and the eff ects on autoph-
agy were observed in a cell-type independent manner. Thus, our study provides direct evidence that MITF 
has rate-limiting and specifi c functions in autophagy regulation. Collectively, the MITF-MIR211 axis con-
stitutes a novel and universal autophagy amplifi cation system that sustains autophagic activity under 
stress conditions.
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Contact dermatitis (CD) is caused by various substances that exert irritant (toxic) eff ects or induce 
immune responses (allergic reactions) and may manifest as Irritant CD and Allergic CD and. Irritant CD 
is a nonspecifi c skin response to direct chemical skin damage and/with releasing infl ammatory mediators, 
while Allergic CD is a delayed hypersensitivity reaction (type IV) to allergens which includes immuno-
logical responses (due to the interaction of T cells and cytokines). Thereby, contact skin lesions may be the 
consequences of contact with various irritants or allergens, or due to other factors (e.g., UV radiation, 
microbials), intrinsic factors (e.g. in autoimmune responses) or even by a combination of both. Impaired 
barrier function also participates by promoting bacterial biofi lms and creating an environment favoring 
sensitization. The development of Allergic CD skin lesions includes complex immunological pathways 
and infl ammatory mediators, infl uenced by both genetic (predominantly fi laggrin mutations) and envi-
ronmental triggers. In the pathogenesis of Allergic CD the role of antimicrobial peptides (AMP) is promi-
nent; but also other factors such as alarmins, proteases, immunoproteomics, lipids, natural moisturizing 
factors, tight junctions, smoking, etc. However, based on many current investigations, future perspectives 
may reveal new pathogenetic factors and scientifi c data important for the work and treatment of CD 
patients.
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The term cutaneous pseudolymphoma refers to a heterogeneous group of benign skin disorders that 
simulate cutaneous lymphomas histologically and sometimes clinically. The diagnosis of B cell pseudo-
lymphoma requires a representative biopsy (excisional biopy) which should be evaluated for morphology, 
growth patt ern, and immunophenotype. We treated a female patient, aged 33, presented with the painful, 
erythematosus, radiant tumor formation at skin in the temporal region. The patient had enlarged lymph 
nodes on the right side of the neck before the appearance of that tumor formation. The dermatoscopic fi nd-
ing was nonspecifi c. After the tumor biopsy was done, histologically the diagnosis of reactive lymphatic 
proliferation – pseudolymphoma or cutaneous lymphoma of B-cell immunophenotyp was set. After we 
had completely excised the change and had sent it to the immunohistochemical analysis, the fi nding hinted 
at fl uorid skin lymphocyte hyperplasia of B- and T- lymphocytes. The results of other fi ndings were nor-
mal (serologic test on Borelia Burgdorferi, ultrasound scan of the neck’s lymph nodes, supraclavicular, 
and of the axillary nodes, nodes in inguinal canal and abdomen. Finally, the etiology remains unknown. 
In conclusion, the diagnosis of B cell pseudolymphoma requires a skin biopsy for histopathologic evalua-
tion and immunophenotyping. In areas endemic for Lyme disease, patients with cutaneous B cell pseudo-
lymphomas should undergo laboratory investigations for Borelia burgdorferi infection. B cell pseudolym-
phomas may resolve spontaneously over time. In clinical practice, lesions are often initially treated with 
topical or intralesional corticosteroids, but refractory lesions may be treated with surgical excision or 
radiotherapy.
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Integrins are heterodimeric glycoproteins that bind cells to extracellular matrix proteins. Upon integ-
rin clustering, multimolecular integrin adhesion complexes (IACs) are formed, facilitating the linkage 
between integrins and the actin cytoskeleton and permitt ing bidirectional signalling. The αV integrin is 
expressed in most tumour cells, where it regulates an array of cellular functions and plays a role in anti-
tumour drug resistance. The aim of this work was to assess αV-dependent changes in IAC composition in 
MDA-MB-435S melanoma cells in order to bett er understand the increased sensitivity to paclitaxel and 
vincristine upon integrin αV knockdown. Integrin αV-specifi c shRNA was cloned into pSUPER.puro, 
transfected into MDA-MB-435S cells using Lipofectamine, and cell clones were selected using puromycin. 
The sensitivity of cells to antitumor drugs was determined using an MTT assay. Cell migration was moni-
tored using a Transwell assay. IACs were isolated following crosslinking and their molecular composition 
analysed using mass spectrometry (MS)–based proteomics. In two MDA-MB-435S-derived cell clones 
with decreased expression of integrin αV, expressing 15% (2αV) or 5% (3αV) of the control cells amount, 
increased sensitivity to paclitaxel and vincristine, decreased sensitivity to cisplatin, and decreased migra-
tion were observed. This data is consistent with previous results obtained following transient transfection 
with integrin αV siRNA. Cell clones 2αV and 3αV were smaller than the control cells and had lower num-
ber of focal adhesions as observed by interference refl ection microscopy and immunofl uorescence detec-
tion of phospho-paxillin, vinculin, talin and phospho-Src. MS analysis of isolated IACs from control MDA-
MB-435S, 2αV and 3αV cells identifi ed 282 proteins, including 36 out of 60 consensus adhesome proteins. 
As expected, in clones 2αV and 3αV, integrins αV, β3 and β5 were detected at much lower levels compared 
to control cells. In addition, lower levels of alpha-actinin-1 and -4, AHNAK, fi lamin-A and -B, HSP-70, 
liprin β1, plectin, talin-1, tensin-3, vimentin, and vinculin were detected. These data will enable follow-up 
analyses of signalling by integrins αVβ3/β5 and therefore represent a valuable resource to improve our 
understanding of the mechanisms involved adhesion control of cell sensitivity to antitumor drugs and 
metastatic potential.
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Integrins are heterodimeric receptors that mediate signalling across the plasma membrane from the 
extracellular environment to the actin cytoskeleton. Integrin binding to the the extracellular matrix induces 
formation of integrin adhesion complexes (IACs), large protein aggregates on the cytoplasmic tails of inte-
grins. The composition of IACs has been named the adhesome, and some adhesion proteins have been 
identifi ed as promising druggable candidates in cancer therapy. Our recently published data in triple 
negative breast cancer cell line MDA-MB-231 has shown that transient transfection with integrin αV-specifi c 
siRNA increased sensitivity to paclitaxel, vincristine and cisplatin, and decreased migration and invasion. 
Transient knockdown of integrin subunit β5, but not β3, has shown the same eff ect. The aim of this work 
was to assess integrin αV-dependent changes in IAC composition. Plasmid pSUPER.puro or pSUPER.
puro containing integrin αV-specifi c shRNA were transfected into MDA-MB-231 cells using Lipofectamine, 
and two stably transfected cell clones 231sh (control plasmid) and 231shαV (plasmid containing integrin 
αV-specifi c shRNA) were selected using puromycin. Decreased expression of integrin subunit αV and 
integrin heterodimers αVβ3 and αVβ5 was confi rmed using fl ow cytometry and the sensitivity of cells to 
antitumor drugs was determined by using MTT assay. Surprisingly, cell clone 231shαV was shown to be 
less sensitive to paclitaxel, vincristine and cisplatin as compared to 231sh which is not in line with the 
results obtained by transient transfection experiments. IACs were isolated following crosslinking and 
their molecular composition analysed using mass spectrometry (MS)–based proteomics. MS analysis of 
isolated IACs from control 231sh and 231shαV cells identifi ed 426 proteins, including 27 out of 60 consen-
sus adhesome proteins. As expected, in 231shαV clone, integrin αV was detected at much lower levels 
compared to 231sh. In addition, lower levels of various adhesion proteins such as actinin alpha (1 and 4), 
AHNAK, fi lamin (A, B, C), HSP70, myosin 9, plectin, IQGAP1, talin-1, tensin-3, vimentin and vinculin 
were detected. These data will potentiate further analyses of integrin-related signalling. Also, the biologi-
cal basis for the contradictory results of sensitivity to antitumor drugs for transient versus stable knock-
down warrants further exploration.
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During the last decades in the fi eld of metallotherapeutics development, ruthenium(II)-arene com-
plexes with intercalating ligands, have att racted signifi cant att ention, due to their unique chemical and 
biological properties. Three newly synthesized ruthenium(II)-arene complexes: C1 ([(ƞ6-toluene)RuLCl]
PF6), C2 ([(ƞ6-p-cymene)RuLCl]PF6) and C3 ([(ƞ6-benzene)RuLCl]PF6; L=pyrido[2’,3’:5,6]pyrazino[2,3-f]
[1,10]phenanthroline) have been evaluated for in vitro cytotoxic activity on three human neoplastic cell 
lines (A549, A375, LS 174T) and on one human non-tumor cell line (MRC-5), by the MTT assay, in com-
parison to cisplatin as a referent compound. Complexes C1-C3 showed IC50 values in the micromolar 
range below 100 μM on all tested cell lines. Complex C2 displayed cytoselectivity against melanoma A375 
cells (IC50=15.78 μM), observed in four times lower activity in MRC-5 cells and two times lower cytotoxic-
ity than cisplatin, and it has been selected for further analyses of its biological eff ects. Flow cytometry 
analyses revealed that complex C2 induce neither substantial alterations in cell cycle phase distribution 
nor triggers apoptosis or necrosis in A375 cells, indicating distinguish and more specifi c type of action by 
which it manifests its high activity. Drug-accumulation study performed by ICP-MS showed that after 24 
h of treatment with equimolar concentrations (10 μM), complex C2 entered the cells less effi  ciently (1.55 
ng Ru/106 cells) in comparison to cisplatin (28.58 ng Pt/106 cells) and distributed approximately equally in 
the cytosol and membrane/organelle fraction of A375 cells. Investigations in the 3D model of A375 cells, 
disclosed diff erent eff ects of complex C2 and cisplatin on growth of multicellular tumor spheroids 
(MCTSs). While the size of cisplatin-treated MCTSs decreased with time, MCTSs treated with C2 contin-
ued to growth. Calcein-AM/PI dual staining for live/dead analysis of A375 MCTSs revealed preserved 
compactness of C2-treated MCTSs and appearance of dark necrotic core with predominantly live periph-
eral edge of cells, in contrast to cisplatin-induced dispersed spheroids with majority of dead cells. These 
results pointed out completely diff erent mechanism of action of this type of ruthenium(II)-arene com-
plexes versus cisplatin in A375 malignant melanoma cells, and necessity for additional biological studies 
for its potential application as anti-cancer drug candidate.
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Macrophages are the major populations of immune system cells found in the tumor microenviron-
ment. Considering that tumor microenvironmental signals can aff ect macrophages functions, we investi-
gate the infl uence of mammary tumor cells on phagocytic activity of murine macrophages in an in vitro 
model. For this, Raw 264.7 macrophages were cultivated alone or with 4T1 mammary tumor cells or super-
natants of 4T1 mammary tumor cells for 48 hours on glass coverslips in a 24 well plates. The heat inacti-
vated bread yeast particles were added at a 1:10 eff ector target ratio and incubated for two hours. After 
removed non-ingested yeast particles, coverslips were collected at 2 and 24 hours and submitt ed to Giemsa 
stained. Phagocytic index was calculated considering % of macrophages that internalized at least one yeast 
X the average number of fungal cells in these macrophages. In addition, production of nitric oxide and 
hydrogen peroxide were evaluated. Results show that macrophages cultivated with tumor cells presented 
higher phagocytic index, lower production of nitric oxide and unaltered levels of hydrogen peroxide when 
compared with macrophages cultured alone. In contrast, macrophages cultivated with mammary tumor 
cells supernatants demonstrated lower phagocytic index and similar levels of nitric oxide and hydrogen 
peroxide when compared with macrophages cultured alone. In conclusion, these results indicate that sol-
uble factors and mainly physical interactions of mammary tumor cells modulate phagocytic and microbi-
cidal activity of murine macrophages in vitro.
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Sirtuin 3 (Sirt3) is the only member of sirtuin family linked to longevity in humans. In addition, 
important cellular and mitochondrial processes, including reactive oxygen species (ROS) generation are 
integrated through Sirt3. Furthermore, Sirt3 has a promising role in cancer tumorigenesis and treatment, 
but there have been controversies about its role as oncogene or tumor suppressor in diff erent types of 
cancer. Breast cancer is the most frequent cancer among women, and ranks as the fi fth cause of cancer 
death worldwide. Since breast cancer cells have strikingly reduced Sirt3 level, and even 20% of them have 
almost no detectable Sirt3 protein we wanted to examine the eff ect of de novo Sirt3 expression upon treat-
ment with 95% O2 (hyperoxia) in human MCF-7 breast cancer cells model. Since hypoxia is a hallmark of 
various tumors, we hypothesized that hyperoxia would have negative impact on cancer cells, thus provid-
ing therapeutic strategy against their tumorigenic properties. Therefore, in this study we have developed 
human MCF-7 breast cancer cells transfectants expressing the Sirt3 protein in order to test its potential in 
aff ecting the response of these cells upon the hyperoxic treatment, i.e. to clarify whether it sensitizes or 
makes these cancer cells more resistant to oxidative stress. De novo expression of Sirt3 decreased meta-
bolic activity and cellular growth of MCF-7 cells, induced metabolic switch from glycolysis to oxidative 
phosphorylation, and decreased abundance of senescent cells. These eff ects were enhanced upon hyper-
oxic treatment: induction of DNA damage and upregulation of p53, with increase of ROS levels followed 
by mitochondrial and antioxidant dysfunction, resulted in additional reduction of metabolic activity and 
inhibition of cellular growth and survival. The mitigation of tumorigenic properties and enhancement of 
the susceptibility of the MCF-7 breast cancer cells to the hyperoxic treatment upon de novo Sirt3 expres-
sion, indicates that the impact of these factors, individually and in combination, should be further explored 
in vitro and particularly in vivo in breast cancer malignancies.
Lib Oncol. 2018;46(Suppl 1):35–89
76
P40: THE HUMAN NME6: EXPRESSION AND SUBCELLULAR LOCALIZATION 
IN TUMOR CELL LINES
BASTIEN PROUST1, MARTINA RADIĆ1, NIKOLINA ŠKROBOT VIDAČEK1, LUCIJA AČKAR1, 
HELENA ĆETKOVIĆ2, MAJA HERAK BOSNAR1
1 Division of Molecular Medicine, Ruđer Bošković Institute, Zagreb, Croatia 
(e-mail: bproust@irb.hr) 
2 Division of Molecular Biology, Ruđer Bošković Institute, Zagreb, Croatia
Nucleoside diphosphate kinase (NDPK/NME/Nm23) family of enzymes catalyze the transfer of 
gamma phosphate from nucleoside triphosphates to nucleoside diphosphates. After the discovery of 
tumor metastasis regulation activity of NME1, this protein family sparked considerable interest in the 
scientifi c community. The Group I members (NME1-NME4) are highly conserved in their amino acid 
sequence and exhibit NDPK activity, while Group II (NME5-NME9) members display less homology and 
seem to lack NDPK activity, with a possible exception of NME6. Although litt le is known about Group II 
members, those evolutionary very old genes are presumed to participate in one or more basic cellular 
process. Therefore, we focused our studies on revealing the subcellular localization, quaternary structure 
and function of Group II human NME6 protein. The expression of NME6 was screened in several human 
tumor cell lines by Western blot, using specifi c anti-NME6 antibodies. Subcellular localization has been 
addressed using immunofl uorescence coupled with confocal microscopy and confi rmed by cell fraction-
ation followed by Western blot analysis. CRISPR/Cas9 genome editing system was used for generating 
NME6 “knock-out” clones.
All human tumor cell lines studied express signifi cant amounts of NME6 protein. Immunofl uores-
cence revealed the colocalization of NME6 predominantly with mitochondria. The cell fractionation con-
fi rmed the presence of NME6 in the mitochondrial fraction although human NME6 protein does not pos-
sess the mitochondrial targeting sequence. Only monoallelic NME6 “knock-out” clones were produced, 
indicating that NME6 plays a signifi cant role in cell survival. Further studies will be conducted to detect 
the NME6 potential NDPK activity, quaternary structure, its function in cellular processes and potential 
role in cancer.
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The tumor suppressor protein p53 has been described as “the guardian of the genome” because of its 
role in conserving genome stability. p53 is mutated in more than 50% of human cancers increasing the 
oncogenic potential. In metastatic melanoma, p53 is rarely mutated, but, nevertheless fails to execute its 
tumor suppressor activity. We hypothesize that in malignant melanoma p53 function might be impaired 
by interactions with yet unknown proteins. Therefore, we are testing possible interactions of p53 with its 
family members, namely p53 and p73 isoforms and with members of the nm23/NDPK protein family, 
nm23-H1 and nm23-H2.
Experiments were performed with and without the induction of DNA damage, assuming that certain 
interactions occur only in specifi c cellular events such as genotoxic stress. Co-immunoprecipitation exper-
iments in cell lines expressing wild-type p53 show interactions of endogenous p53 with several p73 iso-
forms. DNA damage treatment has enhanced p53-ΔNp73 binding affi  nity. The subcellular dynamics and 
co-localization of interacting partners were determined using live cell imaging. The results show that p53 
mainly localizes in the nucleus, but occasionally enters the cytosol, p73 isoforms remain in the nucleus 
while Nm23 proteins, mainly localize in the cytosol but translocate to the nucleus upon DNA damage.
Our future plans will involve advanced confocal microscopy techniques, FRET/FLIM, in order to 
quantify and localize the detected protein interactions. We hope that determination of the nature and 
localization of p53 protein interactions will lead to a bett er understanding of its behavior in melanoma.
Lib Oncol. 2018;46(Suppl 1):35–89
78
P42: SOX2 CANNOT BE USED AS A PREDICTIVE MARKER 
FOR RADIORESISTANCE OF COLORECTAL CANCER
VELDA SMAJLBEGOVIĆ1, SNJEŽANA RAMIĆ2, MELITA PERIĆ BALJA2, IVA KIRAC2, 
ANDRINA KOPJAR3, ELIZABETA HORVATIĆ4, DANKO VELIMIR VRDOLJAK5
1 Oncology Clinic, Clinical Centre of Sarajevo University, Bosnia and Herzegovina 
(e-mail: snjezana.ramic@zg.t-com.hr) 
2 Department of Genetic Counseling, University Hospital for Tumors, Sestre milosrdnice University Hospital 
Center, Zagreb, Croatia 
3 Department of Pathology, General Hospital Varaždin, Varaždin, Croatia 
4 Department of Pathology, Dr. T. Bardek General Hospital Koprivnica, Koprivnica, Croatia 
5 Department of Surgical Oncology, University Hospital for Tumors, Sestre milosrdnice University Hospital 
Center, Zagreb, Croatia
Neoadjuvant long course chemoradiotherapy (LCCRT) in patients with locally advanced rectal can-
cer reduces the tumour mass and local recurrence, downstages the pathologic extent of the tumor and 
enables sphincter preservation surgery. Patients treated with LCCRT but have tumors resistant to such 
therapy have prolonged waiting time to surgical resection without adequate therapy, which can lead to 
tumor progression during that period1. Selection of markers that can predict tumor radiosensitivity is 
necessary. There are several known mechanisms of radioresistance, and generation of cancer stem cells 
(CSC) is one of them2. CSC has self-renewal ability and multilineage diff erentiation potential, and is more 
resistant to various therapeutic treatments2. SOX2 was recently recognized as a gene associated with CSC 
and epithelial-mesenchymal transition that promotes resistance to chemotherapy in ovarian cancer3.
The research was conducted on the assumption that the determination of SOX2 in samples before the 
neoadjuvant chemoradiotherapy could predict tumor resistance to therapy. We evaluated the immunohis-
tochemical expression of SOX2 protein in 62 colorectal carcinoma samples taken from a biopsy before 
LCCRT (Group 1) and matched samples after LCCRT (Group 2). We did not fi nd a signifi cant diff erence in 
SOX2 expression between groups (33.9% vs. 41.8%) (χ2=0.78; P=0.376). Twenty-one patients had good 
pathological response to LCCRT and only 19% of tumors showed SOX2 nuclear staining while tumors 
with poor pathological response to therapy expressed SOX2 in 46.3% of cases (χ2=4.43; P=0.035). Of the 22 
patients who demonstrated progression of the disease after LCCRT and surgery, SOX2 was positive in 
59% of tumors compared to 25% of SOX2 positive tumors in patients without disease progression (χ2=7.07; 
P=0.008). We noticed a discrepancy in SOX2 expression between groups. Thirteen tumors gained SOX2 
expression after LCCRT compared to match samples before LCCRT whereas eleven tumors lost the SOX2 
expression after chemoradiotherapy. Based on our results, nuclear staining of SOX2 is in correlation with 
poor response to therapy and worse prognosis but cannot be used as predictive marker of radioresistance 
of the colorectal cancer.
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Testicular tumors represents 1% of all tumors, but it is public health problem while aff ecting male 
population in reproductive age. Approximately 95 % of all testicular neoplasms are germ cell tumors 
(TGCT) which are classifi ed as pure seminomas (which compose about 55% of all TGCT) and non-semi-
noma group. Important role in their development have (micro)environmental and (epi)genetic factors. 
DNA methylation epimutations are recognized as potential tumor biomarkers because of their high fre-
quency and extreme chemical and biological stability, giving them possible advantage in non-invasive 
diagnostics. Seminoma and non-seminoma TGCT diff er in DNA methylation patt ern.
In this paper results from epidemiological questionnaire collected in studies concerning pure semi-
noma tumors and their relationship with epigenetic changes are presented.
The study is conducted on two groups of examinees; control group (37 healthy volunteers) and 
patients (25 patients with diagnosis of pure seminoma). The participants were informed about the study 
and asked to fi ll in the epidemiological questionnaire. Five groups of questions were asked and targeted 
information about the examinee’s marriage status, present and past environmental factors, life habits and 
life habits of their parents were collected. Statistical SPSS program was used to analyze and compare data 
from the questionnaire.
Average age of healthy volunteers was 27 and of the patients was 35. According to the results, 83.8% 
of volunteers and 52.0% of patients have a hobby, of which 73.0% of volunteers and 40.0 % of patients, 
refers to sport. Moreover, positive answer about current smoking gave 24.3% of healthy people and the 
average number of smoked cigarett es per day amounts for 7. On the other hand, 52.2% of the patients said 
that they smoke and the average number of cigarett es per day is 20. Also, consumption off  vegetables and 
fruits per day among patients is almost 50% lower than among volunteers.
As expected, diff erences in lifestyle were observed between healthy control group and patients. 
Healthy volunteers live healthier, eat healthier food, smoke less and are more active, while patients smoke 
more and are not so active.
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As a part of Royal jelly’s (RJ) biological activity, investigations of its possible antitumour activity as 
well as possible interaction with human interferon-alpha (HuIFN-αN3) were performed. The purpose of 
this study was to investigate the infl uence of RJ on HuIFN-αN3 induced inhibition of Human colorectal 
adenocarcinoma cells (CaCo-2) proliferation and their eff ect on intracellular glutathione (GSH) level and 
lipid peroxidation. The anti proliferative (AP) activity of RJ (0.1 g/10 ml phosphate buff er saline (PBS), 
HuIFN-αN3, (1.000 I.U./ml),10-hidroxy-2-decenoic acid (10-HDA) (100 μM/ml) and diff erent combina-
tions between them in ratio 1:1, 1:2 and 2:1 on CaCo-2 cells were determined. Their infl uence on GSH level 
was measured by glutathione assay kit. The lipid peroxidation was measured by Malondialdehyde (MDA) 
assay. RJ alone exhibits a low AP activity: 2.0 (0.5 mg/ml). HuIFN-αN3 has AP activity of 2.5 (208.33 I.U. /
ml) and 10-HDA has the AP activity 1.5 (37.5μM/ml). In the combination between RJ and HuIFN-αN3 
(2:1), the AP activity was 3.8. In that combination the level of GSH was 24, 9±2, 4 nM/mg of proteins 
(70.2±3.2 nM/mg in Control) and the level of MDA was 72.3±3.1 nM/mg (23.6±9.1 nM/mg in Control). The 
10-HDA as the main component of the RJ is responsible for its infl uence on HuIFN-αN3 inhibition of 
CaCo-2 cells proliferation in vitro. RJ and HuIFN-αN3 in combination 2:1 decrease the level of GSH and 
signifi cantly increase the lipid peroxidation via MDA in CaCo-2 cells.
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Hedgehog signaling pathway is a developmental signaling pathway which is dormant in most adult 
diff erentiated tissues, but aberrantly activated in various tumors. In ovarian tumors it can be activated in 
a canonical way, by the SHH ligand, or the non-canonical way, by upregulation of the GLI transcription 
factors. Usually, only GLI1 expression was associated with tumor progression, but GLI2 and GLI3 also 
play a role by modifying the activity of GLI1 and transcription of their common transcriptional targets. In 
ovarian cancer, GLI3 protein is expressed in the full-length activator form, and not the shortened repressor 
form which is the predominant form for GLI3 protein. To study the roles of the three GLI proteins in detail, 
we used the CRISPR/Cas9 guided gene editing to generate knock-out lines for each of the three GLI pro-
teins. The knock-out was confi rmed by Western blot. The modifi ed cell lines showed diff erences in cell 
morphology compared to the original SKOV3 cell line immediately after expansion from the single cell, as 
well as diff erent response to GANT-61 inhibition on cell cycle, apoptosis and colony forming capabilities 
of the cell lines. This demonstrates that all three GLI proteins are important for survival of ovarian cancer, 
and not only GLI1 as was considered previously.
Lib Oncol. 2018;46(Suppl 1):35–89
82
P46: A META-ANALYSIS AND A COHORT STUDY INDICATE ASSOCIATION 
BETWEEN RASSF1A PROMOTER METHYLATION AND TESTICULAR GERM 
CELL TUMOR
DORA MARKULIN1, ALEKSANDAR VOJTA1, IVANA SAMARŽIJA1, MARIJA GAMULIN2, 
IVONA BEČEHELI3, IRENA JUKIĆ4, ČEDOMIR MAGLOV4, VLATKA ZOLDOŠ1, 
ALEKSANDRA FUČIĆ5
1 University of Zagreb, Faculty of Science, Department of Biology, Division of Molecular Biology, Zagreb, Croatia 
(e-mail: ivana.samarzija@irb.hr) 
2 University Hospital Centre Zagreb, Department of Oncology, Zagreb, Croatia 
3 Genos Glycoscience Research Laboratory, Zagreb, Croatia 
4 Croatian Institute of Transfusion Medicine, Zagreb, Croatia 
5 Institute for Medical Research and Occupational Health, Zagreb, Croatia
The RAS association domain family protein 1a (RASSF1A) is a prominent tumor suppressor similar 
to RAS eff ector proteins. It shows altered promoter methylation in many diff erent cancer types including 
testicular germ cell tumors (TGCT). TGCT are the most common malignancy in young men and they 
account for approximately 1% of all human malignancies. RASSF1A promoter hypermethylation might 
represent an early event in TGCT tumorigenesis. In addition to epigenetic studies on tumor tissue, in the 
last decade, there have been several reports showing correlation between peripheral blood DNA methyla-
tion and tumor status. Given the fact that peripheral blood is easily accessible, it is clear that its DNA 
methylation analysis holds a promise in fi nding suitable cancer markers. We investigated whether the 
RASSF1A promoter methylation in peripheral blood of TGCT patients can be associated with testicular 
cancer risk. Following a meta-analysis, we performed a cohort study including 32 testicular cancer patients 
and 32 healthy controls. Promoter methylation of the RASSF1A and O6-methylguanine-DNA-methyl-
transferase (MGMT) genes was analyzed using bisulfi te pyrosequencing of DNA from peripheral blood. 
Meta-analysis showed an odds ratio (OR) of 7.69 for RASSF1A promoter methylation as a risk factor for 
TGCT. Cohort study found altered methylation of the RASSF1A promoter in blood of TGCT patients. 
Methylation was higher in TGCT patients before BEP (bleomycin, etoposide, cisplatin) chemotherapy. The 
meta-analysis indicates a role of the RASSF1A promoter hypermethylation from peripheral blood in 
TGCT. We confi rmed the fi ndings of meta-analysis (encompassing mainly tumor tissue) in our cohort 
study, which represents the fi rst report of changed RASSF1A promoter methylation in peripheral blood 
TGCT. We envision that further studies including larger number of patients will bring more light into the 
potential of using RASSF1A peripheral blood methylation status as a TGCT marker.
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Low survival rates of patients with metastatic triple negative breast cancer (TNBC) and melanoma, in 
which current therapies are ineff ective, emphasize the need for new therapeutic approaches. Integrin sig-
naling regulates proliferation, migration, metastasis and cell death and has been suggested as a possible 
target in antitumor therapy. Although seen as a promising target when combined with chemotherapy, 
recent data on integrin β1 have shown that its inactivation increases metastatic potential due to the com-
pensatory upregulation of other integrin subunits. Therefore, the aim of this study was to investigate the 
potential of integrin subunits αv, α3 or α4 knockdown in increasing sensitivity in seven TNBC (MDA-
MB-231, -468 and -436) and melanoma (MDA-MB-435S, RPMI-7951, MeWo and A375) cell lines to cispla-
tin, microtubule poisons paclitaxel (PTX) and vincristine (VCR), and mitigating metastatic potential. 
Experiments performed in integrin αvβ1 negative melanoma cell line MDA-MB-435S identifi ed integrin 
subunit αv as a target whose knockdown increases sensitivity to vincristine or paclitaxel, and decreases 
migration and invasion. In MDA-MB-435S cell line we also identifi ed a phenomenon in which change in 
expression of one integrin subunit changes the expression of other integrin/s, leading to an unpredictable 
infl uence on sensitivity to anticancer drugs and cell migration referred to as the integrin switching eff ect. 
The contribution of integrins αv versus integrins αvβ3/β5 was also assessed in a panel of six TNBC and 
melanoma cell lines by the combined action of αv-specifi c siRNA or αvβ3/β5 inhibitor cilengitide with 
paclitaxel. Knockdown of integrin αv in combination with VCR and PTX resulted in benefi cial eff ect in all 
three TNBC cell lines, while in melanoma cell lines we observed benefi cial eff ect in only one cell line out 
of three. Interestingly, cilengitide-driven inactivation of integrin heterodimers αvβ3 and αvβ5 showed 
benefi cial eff ect in combination with PTX in fi ve out of seven TNBC and melanoma cell lines, although in 
a diff erent set of cells as compared to integrin αv knockdown. Our results suggest that for TNBC the 
knockdown of integrin αv in combination with paclitaxel presents a bett er therapeutic option than cilen-
gitide, and simultaneously decreases migration and invasion. However, in melanoma neither of these 
combinations is advisable because decreased sensitivity to paclitaxel was observed.
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DNA-protein crosslinks (DPCs) are DNA lesions formed by a protein irreversibly covalently bound 
to DNA. DPCs are common lesions which present a physical blockage to all DNA transactions. If DPCs are 
left unrepaired, they cause genomic instability, premature aging and liver cancer in mice and humans. 
Recently, several groups have identifi ed proteases Wss1 and SPRTN which initiate the removal of DPCs 
through the proteolytic digestion of crosslinked proteins. These discoveries led to recognition of DNA-
protein crosslink repair (DPCR) as a separate DNA damage repair pathway. After SPRTN proteolysis of 
DPCs, peptide remnant of unknown size remains crosslinked to the DNA backbone, and is subsequently 
removed by unknown factors. Few in vitro studies have shown that small DPCs (below 8-16 kDa) can be 
removed by Nucleotide Excision Repair (NER), and therefore NER remains one of the possible candidates 
for peptide excision downstream of SPRTN proteolysis. However, litt le is known about the role of NER on 
the organismal level. The goal of our study was to determine if and under which conditions is NER 
involved in DPC repair in vivo using zebrafi sh (Danio rerio) and CRISPR/Cas9 gene manipulations. 
Among the NER components, we have chosen to target XPA (Xeroderma pigmentosum complementation 
group A) for gene knock-out (KO) because: A) other NER factors are involved in other cellular processes 
while XPA is considered to be specifi cally involved in NER, and B) XPA KO is not embryonic lethal. Our 
study is still in progress and will reveal actual contribution of NER pathway to the DPC removal on the 
organismal level.
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Testicular germ cell tumors (TGCT) are the most prevalent malignancies in young men.They arise 
from primordial germ cells that had impaired maturation to prespermatogonia and spermatogonia. In 
earliest stages of TGCT development, somatic mutations are believed to be uncommon and it is therefore 
likely that epimutations, that are reversible, are drivers in their development. Experimental mouse tera-
toma is a well-established in vitro model for studying TGCT development. Namely, a week long cultiva-
tion of embryonic shield results in developing teratoma-like structures. We isolated embryonic shield 
from 7,5 days old mouse embryos, treated them for two hours with epigenetic modulators that infl uence 
methylation (5-azacytidine), histone acetylation (Trichostatin A, Valproate) and translation of mRNA 
(esiNanog, esiOct3/4 and esiTrrap) and then cultured them in MEM enriched with rat serum. Growth of 
embryonic shields/teratomas was followed by measuring their size at each day of cultivation. On day 7 
teratomas were collected. To investigate eff ect of used epigenetic modulators on cell stamness, DNA meth-
ylation status of promoter regions of Nanog, Oct3/4 and Sox2 genes as well as quantifi cation of mRNA of 
these genes was performed. Furthermore, the expressions of endoderm (Sox17, Gata4), mesoderm (Brachy-
ury, Eomes), neuroectoderm markers (Nestin, Sox2, Six3), marker of primitive ectoderm (Fgf5) and marker 
of myogenic commitment (MyoD) were determined. Epigenetic agents signifi cantly reduced embryonic 
shields/teratomas growth. The strongest decrease was detected in esiOct3/4 treated group followed by 
5-azacytidine, Valproate and Trichostatin A treated groups. 5-azacytidine decreased methylation in pro-
motor regions of stemness genes. The highest increment of DNA methylation was achieved by esiNanog 
for Nanog gene and by esiOct3/4 for Oct3/4 gene. Expression of analysed stemness markers was signifi -
cantly reduced by Valproate which also reduced expression of mesodermal, neuroectodermal markers 
and marker of myogenic commitment. EsiOct3/4 treated group showed the most prominent eff ect on 
mesoderm and primitive ectoderm marker expression. In conclusion, it seems that various epigenetic 
modulators impact experimental germ cell tumor development in vitro via methylation alternations in 
promotors of stemness and diff erentiation genes and their expression. Epigenetic modulators have poten-
tial for reverting epimutations and therefore restoring appropriate gene expression.
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The Hedgehog-GLI (HH-GLI) signaling pathway is primarily associated with embryonic develop-
ment but in the last two decades its role in cancer development has become intensely studied. The HH-GLI 
pathway is associated with one third of cancer related deaths, which makes it an interesting new therapeu-
tic target. Recent research indicates that the HH-GLI pathway could be a key player in prostate cancer 
development and progression, as well as in the development of resistance to therapeutics. The aim of this 
study is to investigate the activity of the HH-GLI pathway in prostate cancer tissue samples in comparison 
with healthy prostate tissue samples and samples of prostate infl ammation.
Around 30 formalin-fi xed paraffi  n-embedded prostate tissue samples per group were collected from 
prostate cancer patients (Grade Group I-V) and two controls groups (benign prostate tissue and prostate 
infl ammation). Expression of GLI3 and PTCH1 proteins was determined immunohistochemically. The 
level of protein staining was expressed by multiplying percentage of positive stained cells and staining 
intensity (histoscore), separately for prostate epithelium and stroma. Localization of protein staining 
(nuclear and/or cytoplasmic) was also determined.
Both GLI3 and PTCH1 histoscores were signifi cantly higher in epithelial prostate cancer cells (P<0.0001 
for both proteins) compared to controls, but not in prostate stroma (P=0.835 for GLI3 and P=0.175 for 
PTCH1). GLI3 and PTCH1 expressions were positively correlated (rho=0.48, P<0.0001). Localization of 
GLI3 in epithelium was generally mostly diff use (both nuclear and cytoplasmic), while in prostate cancer 
stroma cytoplasmic localization of GLI3 was negatively associated with higher Grade Group (P<0.0001). 
The same was observed for PTCH1 localization in prostate cancer epithelium and stroma (P<0.0001 for 
both). In control samples of prostate infl ammation prevails cytoplasmic PTCH1 expression, while in 
benign prostate tissue it is mostly diff use. The expression of all HH-GLI pathway components has been 
found in the androgen-dependent prostate cancer cell line LNCaP. Interestingly, after exposure of these 
cells to androgen-deprived conditions, the expression of GLI3 was signifi cantly upregulated.
Our study has determined an increased activity of HH-GLI pathway in prostate cancer, and a poten-
tial role for GLI3 in androgen-independent growth. However, its relation to prostate cancer progression 
and mechanisms of sustaining androgen independent growth have yet to be determined. Our results 
showing higher nuclear localization of GLI3 in higher Grade Group could indicate an increase in paracrine 
HH-GLI signaling, from the tumor cells toward the stroma.
This study was funded by dm-drogerie markt donation.
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Breast cancer (BC) is the most common malignancy in women. Common risk factors are age, hor-
monal factors, reproductive and menstrual history, exposure to radiation, obesity and genetic background. 
Genetic variation can aff ect both susceptibility and prognosis. Survivin, encoded by BIRC5 gene (baculo-
viral IAP repeat containing 5), belongs to the family of inhibitors of apoptosis proteins (IAPs). In mam-
malian cells it participates in the control of mitosis, apoptosis regulation and cellular stress response. Its 
expression is increased in almost all cancer types. The aim of this study was to investigate the role of 
BIRC5 polymorphisms in BC and to correlate survivin expression with various clinicopathological charac-
teristics including age of onset, time since operation, histological grade, tumor type and size, lymph node 
status, estrogen, progesterone, Her2 and Ki67 status.
Blood and FFPE tumor tissue samples were collected from 26 Croatian BC patients. Majority had 
invasive ductal carcinoma (81.5%). Survivin expression was determined immunohistochemically and 
scored between 1 and 3 taking into account percentage of positive cells and staining intensity. BIRC5 pro-
moter, coding region and 3’UTR were genotyped using high resolution melting analysis and Sanger 
sequencing. Genomic DNA from 74 healthy women was used as control.
Numbers of samples with survivin expression with a score 1, 2 and 3 were 9 (33.3%), 11 (40.7%) and 
7 (25.9%), respectively. Most patients had nuclear survivin staining (92.6%). High survivin expression was 
associated with negative ER status (p=0.007) and positive Ki67 expression (p=0.032). Ki67 expression was 
also positively associated with histological grade (p=0.0009). Fourteen polymorphisms were found in BC 
samples, located mostly in promoter and 3’UTR. There were no signifi cant diff erences in polymorphisms’ 
frequencies between BC and control samples. However, age of onset was associated with fi ve BIRC5 poly-
morphisms (c.-1547C>T, c.-644T>C, c.-241C>T, c.9386T>C and c.9809T>C).
This was the fi rst study investigating the possible role of BIRC5 polymorphisms in breast cancer etiol-
ogy conducted in Croatia. Although no association of any of BIRC5 polymorphism with BC or level of 
survivin expression was observed, several polymorphisms were associated with the age of onset. Further 
research with a larger sample size is needed to assess the signifi cance of BIRC5 polymorphisms and sur-
vivin expression as predictive/prognostic biomarkers for BC.
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Pancreatic ductal adenocarcinoma (PDAC) is one of the most lethal cancers. Despite signifi cant eff ort 
in developing novel detection and therapeutic strategies in the last decades, the fi ve-year survival rate 
remains just around 5–7%. It is projected that by 2030 PDAC will become the second leading cause of 
cancer-related death. New therapeutic targets in PDAC are urgently needed. In this study, we examined 
the expression of nischarin in PDAC, an integrin binding protein that is in humans encoded by the NISCH 
gene. Nischarin’s potential tumor-suppressive eff ect has been shown in breast and ovarian cancer. The 
expression of NISCH is signifi cantly reduced in human breast cancer tissue compared to normal. NISCH 
overexpression can induce apoptosis, inhibit cell migration and invasion of breast cancer cells in vitro, and 
reduce tumor growth and metastasis in in vivo models of breast cancer. Nischarin eff ects in other types of 
cancer are unknown. The aim of our study was to examine the expression patt ern of nischarin in PDAC 
and its potential role in progression of the disease. UALCAN, the interactive web resource for analyzing 
cancer transcriptome data from TCGA database, was used to analyze the association between NISCH 
expression levels and PDAC sample characteristics. Analysis indicated that NISCH expression was 
decreased in stage II (n=146, median=57.851, P=0.0743) and stage III (n=4, median=39.546, P=0.0631) PDAC 
tumors compared with the normal tissue (n=4, median=80.72). For survival analysis, the patients from 
TCGA PDAC database (n=174) were divided into two groups based on the mean of nischarin expression 
of the entire population. Patients with low-expressing nischarin (below the mean, n=99 patients) had poor 
prognosis, while patients with high-expressing nischarin tumors (above the mean, n=75 patients) showed 
statistically signifi cant increase in overall survival (ratio of survival=1.268, 95% CI=0.8245 to 1.95, log-rank 
P=0.0177). These results imply that nischarin may be used as a prognostic marker for patients with PDAC. 
As the role of nischarin in cancer is not fully elucidated, our future study will focus on NISCH role in 
PDAC and its potential as a druggable target for more eff ective PDAC treatment.
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Patients suff ering from head and neck squamous cell cancer (HNSCC) still have low survival rate due 
to late diagnosis, insuffi  cient knowledge on chemo- and radioresistance and lack of reliable prognostic and 
predictive biomarkers. As IL-6 defi nes the tumorigenic capacity and motility of cancer stem cells there is 
raised interest for its inclusion as a marker of cancer aggressiveness and concomitant decision upon ther-
apy. The aim of this study was to investigate stromal and epithelial IL-6 levels in HNSCC.
Analysis of IL-6 in 51 HNSCC (24-non-metastatic and 26 metastatic cancers) patients who underwent 
radical surgery was performed by immunohistochemistry in the tumour epithelium and in the tumour 
stroma. Mean age of patients was 63±12 years.
IL-6 values in the epithelium and stroma positively correlated (Spearman’s rho 0.69, p-value < 0.001). 
IL-6 was higher in patients with metastases than in non-metastatic patients, and this diff erence was more 
pronounced in the stroma (median 18.00 with interquartile range [10.00, 57.50], compared to 8.00 [1.00, 
18.50] in patients without metastases) than in the epithelium (20.00 [10.00, 37.50] versus 11.50 [5.00, 30.00]).
Our results suggest that (a) stromal IL-6 might be the marker of neoplastic progression, (b) need for 
both stromal and epithelial IL-6 analysis in patients with HNSCC. Stromal production of IL-6 may contrib-
ute in the future profi ling of tumor aggressiveness, poor response to the chemoradiotherapy and regard-
ing decision on immunotherapy.
